September 24, 2024

Lisocabtagene maraleucel (Breyanzi®) was first approved by the U.S. Food and Drug Administration (FDA) in 2021 for patients with relapsed or refractory large B-cell lymphoma (LBCL), high-grade B-cell lymphoma, primary mediastinal large B-cell lymphoma, and grade IIIB follicular lymphoma. In 2022, the FDA expanded its approval for the initial indication to include those with refractory disease or relapse within 12 months of first-line chemoimmunotherapy who are not eligible for hematopoietic stem cell transplantation.

September 19, 2024

Mucositis is a common side effect of many cancer treatments, with incidence rates of 40% in patients receiving chemotherapy, 80% in patients receiving hematopoietic stem cell transplantations, and up to 100% in patients receiving radiation therapy for head and neck cancer. The literature reports mucositis less frequently with targeted agents and immunotherapies; however, it should be considered in an advance practice provider’s approach to overall immune-related adverse event prevention, assessment, and management. 

September 18, 2024

“A strong body of evidence highlights the importance of physical activity and healthy eating during post-treatment survivorship to improve or maintain body composition, decrease the risk of cancer recurrence, and positively affect all-cause mortality,” oncology nurse investigators said in a review of clinical guidelines published in the Clinical Journal of Oncology Nursing. In their article, the authors provided an overview of the current evidence-based nutritional and activity recommendations for cancer survivors and the oncology nurse’s role in educating and promoting adhere

September 17, 2024

Oxaliplatin (Eloxatin®) is a platinum-based drug used since 2002 to treat colorectal cancer. It can cause serious hypersensitivity adverse reactions and has the unique side effect of reversible peripheral sensory neuropathy exacerbated by exposure to cold temperature or objects. It gets its name from its chemical structure, which has an oxalate ligand.

September 12, 2024

Five months into my oncology fellowship, I was tasked with my first solo consultation during the first week of my palliative rotation. I entered the room and was struck by how young and calm Jane was.

September 06, 2024

In 2008, Feeding America established September as Hunger Action Month to bring together food banks, food pantries, and local meal programs to raise awareness about hunger and inspire people to take action. Here are some ways that you can advocate for patients with cancer who are experiencing food insecurity this month.